Fruzaqla Capsule
Product Images NDC 63020-210

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fruzaqla (NDC 63020-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fruzaqla01)

Chemical structure of fruquintinib, the active ingredient in Fruzaqla capsules. The structure features multiple aromatic rings, including a pyridine ring and methoxy-substituted benzene, with various functional groups such as carbonyl, amide, and methyl groups.*

FDA Label Image

Figure1 (Fruzaqla02)

A Kaplan-Meier survival curve comparing the probability of overall survival over time in months between patients treated with Fruzaqla plus best supportive care (BSC) and those treated with placebo plus BSC. The chart includes patient numbers at risk for both groups across different time points up to about 19 months.*

FDA Label Image

Figure2 (Fruzaqla03)

A Kaplan-Meier survival curve chart comparing the probability of overall survival between patients treated with Fruzaqla plus best supportive care (BSC) and those given placebo plus BSC over a 24-month period. The chart includes patient risk counts displayed below the time axis for each treatment group.*

FDA Label Image

Principal Display Panel (1 mg Capsules)

Packaging label for Fruzaqla 1 mg capsules, containing fruquintinib, an oral prescription drug. The label shows a package size of 21 capsules, distributed by Takeda Pharmaceuticals America, Inc. The label includes storage instructions, trademark information, and barcode details. The labeler is Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (1 mg Capsules)

Packaging label for Fruzaqla 5 mg capsules, containing fruquintinib, an oral prescription drug. The label indicates a 21-capsule count and features the Takeda Pharmaceuticals America, Inc. logo. It includes storage instructions, distributor information, and trademark notices. The NDC number 63020-225-21 and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.